Friday's Gilead and Incyte gap-ups, against the Nasdaq's worst session since June, look less like a coincidence and more like…
Month: October 2026
OPay’s Withdrawn IPO Is a Warning About Chasing New Issues
Friday’s sequence at the NYSE was close to unprecedented. OPay priced 16 million American depositary shares at $19 and rang…
Toyota Reports Thursday. The Yen Is Doing a Lot of the Work.
Toyota reports fiscal first-half results on Thursday, November 5. Analysts expect $3.37 per share on revenue of $84.74 billion. A…
Your book is inside
A note from our friends at Tradewins(ad) Blane Markham here. Alert! If you still haven’t saved your copy of Options…
A back door into Anthropic that costs under $100
October 31, 2026 Bonus Content: Lilly Beat Estimates by $1.8 Billion. The Third Raise Matters More. A note from our…
Rickards: “January 27 Market Crash Will Be 10X Worse than 2008”
October 31, 2026 Bonus Content: Amazon’s Cloud Is Growing 39%. Capex Is the Real Test. A note from our friends…
The most dangerous moment in a financial crisis
October 31, 2026 Bonus Content: EQT Is Buying Range Resources. Natural Gas Just Became the AI Trade. A note from…
Berkshire’s $365 Billion Is Earning Real Money. Monday Shows Whether Abel Spends More of It.
With the Nasdaq 100 in correction and Q3 results due before Monday's open, Greg Abel's cash discipline is both a…
Regeneron Reports Q3 2026 With a Clearer Dupixent Profit Share
The stock is down about 31% from its August 2024 high. Today's Q3 report should show what Dupixent is really…
AbbVie’s Dividend Is Growing Because Its Drugs Are Growing
61% of Americans Worry America Could be on the Verge of Another Civil War In Today’s News Your Options Checklist…
